Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Sherwin

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Maximum tolerated doses of preparations from different manufacturersS A Sherwin
Genetics|October 1, 1971
Suppression of tryptophan mutants in Bacillus subtilis by apparent nonsense suppressorsS A Sherwin, B C Carlton
Journal of Cellular Biochemistry|January 1, 1985
Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastroneD R Twardzik, S A Sherwin
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1979
A new endogenous primate type C virus isolated from the Old World monkey Colobus polykomosS A Sherwin, G J Todaro
Maryland State Medical Journal|December 1, 1982
The organization of a National Cancer Institute Clinical Research Unit in a community settingV J Suppers, S A Sherwin
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfacesS A Sherwin, A H Sliski, G J Todaro
Cancer Research|June 1, 1987
Phase I study of recombinant tumor necrosis factor in cancer patientsM Blick, S A Sherwin, M Rosenblum, et al.
International Journal of Cancer|January 15, 1978
Complement-mediated lysis of type-C virus: effect of primate and human sera on various retrovirusesS A Sherwin, R E Benveniste, G J Todaro
Virology|April 30, 1979
The isolation of an endogenous retrovirus from the New World rodent Dasyprocta punctata (agouti)S A Sherwin, T I Bonner, U Heine, et al.
Journal of Biological Response Modifiers|February 1, 1987
Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinomaJ R Quesada, R Kurzrock, S A Sherwin, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Maximum tolerated doses of preparations from different manufacturersS A Sherwin
Genetics|October 1, 1971
Suppression of tryptophan mutants in Bacillus subtilis by apparent nonsense suppressorsS A Sherwin, B C Carlton
Journal of Cellular Biochemistry|January 1, 1985
Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastroneD R Twardzik, S A Sherwin
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1979
A new endogenous primate type C virus isolated from the Old World monkey Colobus polykomosS A Sherwin, G J Todaro
Maryland State Medical Journal|December 1, 1982
The organization of a National Cancer Institute Clinical Research Unit in a community settingV J Suppers, S A Sherwin
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Human melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfacesS A Sherwin, A H Sliski, G J Todaro
Cancer Research|June 1, 1987
Phase I study of recombinant tumor necrosis factor in cancer patientsM Blick, S A Sherwin, M Rosenblum, et al.
International Journal of Cancer|January 15, 1978
Complement-mediated lysis of type-C virus: effect of primate and human sera on various retrovirusesS A Sherwin, R E Benveniste, G J Todaro
Virology|April 30, 1979
The isolation of an endogenous retrovirus from the New World rodent Dasyprocta punctata (agouti)S A Sherwin, T I Bonner, U Heine, et al.
Journal of Biological Response Modifiers|February 1, 1987
Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinomaJ R Quesada, R Kurzrock, S A Sherwin, et al.
Pageof 6